[144] KEWAUNEE SCIENTIFIC CORP /DE/ SEC Filing
Rhea-AI Filing Summary
Form 144 notice by an insider of Kewaunee Scientific Corp (KEQU) discloses a proposed sale of 1,000 common shares through Fidelity Brokerage Services (Boston) with an aggregate market value of $42,720, and lists prior open-market sales by the same person totaling 5,000 shares across five transactions between September 18–29, 2025, generating gross proceeds shown for each trade. The 1,000 shares were acquired as a stock award on June 30, 2024 and were issued as compensation. The filer certifies they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 notice reporting a proposed sale of stock-awarded shares and recent small open-market dispositions by an insider.
This Form 144 documents a prospective sale of 1,000 common shares acquired as a stock award on 06/30/2024, to be executed via Fidelity with an indicated market value of $42,720 and an approximate sale date of 09/30/2025. The filing also lists five recent sales by the same individual totaling 5,000 shares during 09/18–09/29/2025 with reported gross proceeds per trade. From an investor-materiality perspective, these disclosures are procedural under Rule 144 and provide transparency about insider liquidity but do not by themselves indicate company performance or new material events.
TL;DR: Compliance-focused disclosure showing insider is selling previously awarded shares and affirming absence of undisclosed material information.
The notice shows adherence to Rule 144 reporting requirements: the securities were acquired as compensation and the filer attests no undisclosed material adverse information exists. The recent sequence of small sales over several days suggests staged disposition consistent with volume-limited insider sales rather than a single large block sale. This filing is governance-compliant and signals routine insider liquidity rather than governance concerns based solely on the disclosed facts.